Mottaran A, Ercolino A, Bianchi L, Piazza P, Manes F, Amirhassankhani S, et al. Twenty years’ experience in retroperitoneal lymph node dissection for testicular cancer in a tertiary referral center. Medicina. 2023;59:133.
Schwen ZR, Gupta M, Pierorazio PM. A review of outcomes and technique for the robotic-assisted laparoscopic retroperitoneal lymph node dissection for testicular cancer. Adv Urol. 2018;2018:2146080.
Google Scholar
Park JS, Kim J, Elghiaty A, Ham WS. Recent global trends in testicular cancer incidence and mortality. Medicine. 2018;97:e12390.
Google Scholar
Crocetto F, Arcaniolo D, Napolitano L, Barone B, La Rocca R, Capece M, et al. Impact of sexual activity on the risk of male genital tumors: a systematic review of the literature. Int J Environ Res Public Health. 2021;18:8500.
Zhang T, Ji L, Liu B, Guan W, Liu Q, Gao Y. Testicular germ cell tumors: a clinicopathological and immunohistochemical analysis of 145 cases. Int J Clin Exp Pathol. 2018;11:4622–9.
Google Scholar
Boccellino M, Vanacore D, Zappavigna S, Cavaliere C, Rossetti S, D’Aniello C, et al. Testicular cancer from diagnosis to epigenetic factors. Oncotarget. 2017;8:104654–63.
Google Scholar
Malkiewicz B, Swirkosz G, Lewandowski W, Demska K, Szczepaniak Z, Karwacki J, et al. Lymph node dissection in testicular cancer: the state of the art and future perspectives. Curr Oncol Rep. 2024;26:318–35.
Google Scholar
Enei Y, Urabe F, Miki J, Iwatani K, Hisakane A, Yasue K, et al. Clear identification of the rare solitary external iliac lymph node metastasis of testicular cancer by using indocyanine green fluorescence guidance. IJU case Rep. 2021;4:163–6.
Google Scholar
Daugaard G, Karas V, Sommer P. Inguinal metastases from testicular cancer. BJU Int. 2006;97:724–6.
Google Scholar
Tang DE, Dai Y, He JX, Lin LW, Leng QX, Geng XY, et al. Targeting the KDM4B-AR-c-Myc axis promotes sensitivity to androgen receptor-targeted therapy in advanced prostate cancer. J Pathol. 2020;252:101–13.
Google Scholar
Berry WL, Janknecht R. KDM4/JMJD2 histone demethylases: epigenetic regulators in cancer cells. Cancer Res. 2013;73:2936–42.
Google Scholar
Young NL, Dere R. Mechanistic insights into KDM4A driven genomic instability. Biochem Soc Trans. 2021;49:93–105.
Google Scholar
Chen Y, Yang S, Yu T, Zeng T, Wei L, You Y, et al. KDM4A promotes malignant progression of breast cancer by down-regulating BMP9 inducing consequent enhancement of glutamine metabolism. Cancer Cell Int. 2024;24:322.
Google Scholar
Chen M, Jiang Y, Sun Y. KDM4A-mediated histone demethylation of SLC7A11 inhibits cell ferroptosis in osteosarcoma. Biochem Biophys Res Commun. 2021;550:77–83.
Google Scholar
Zhao J, Li B, Ren Y, Liang T, Wang J, Zhai S, et al. Histone demethylase KDM4A plays an oncogenic role in nasopharyngeal carcinoma by promoting cell migration and invasion. Exp Mol Med. 2021;53:1207–17.
Google Scholar
Chen DB, Xie XW, Zhao YJ, Wang XY, Liao WJ, Chen P, et al. RFX5 promotes the progression of hepatocellular carcinoma through transcriptional activation of KDM4A. Sci Rep. 2020;10:14538.
Google Scholar
Yang Y, Sheng J, Hu S, Cui Y, Xiao J, Yu W, et al. Estrogen and G protein-coupled estrogen receptor accelerate the progression of benign prostatic hyperplasia by inducing prostatic fibrosis. Cell Death Dis. 2022;13:533.
Google Scholar
Ma X, Su J, Zhao S, He Y, Li S, Yang X, et al. CCL3 promotes proliferation of colorectal cancer related with TRAF6/NF-kappaB molecular pathway. Contrast Media Mol Imaging. 2022;2022:2387192.
Google Scholar
Zhou S, Yang K, Chen S, Lian G, Huang Y, Yao H, et al. CCL3 secreted by hepatocytes promotes the metastasis of intrahepatic cholangiocarcinoma by VIRMA-mediated N6-methyladenosine (m(6)A) modification. J Transl Med. 2023;21:43.
Google Scholar
Ding L, Wang R, Xu W, Shen D, Cheng S, Wang H, et al. PIWI-interacting RNA 57125 restrains clear cell renal cell carcinoma metastasis by downregulating CCL3 expression. Cell Death Discov. 2021;7:333.
Google Scholar
Zi-Chen G, Jin Q, Yi-Na Z, Wei W, Xia K, Wei X, et al. Colorectal cancer cells promote osteoclastogenesis and bone destruction through regulating EGF/ERK/CCL3 pathway. Biosci Rep. 2020;40:BSR20201175.
Maeda S, Hikiba Y, Sakamoto K, Nakagawa H, Hirata Y, Hayakawa Y, et al. Colon cancer-derived factors activate NF-kappaB in myeloid cells via TLR2 to link inflammation and tumorigenesis. Mol Med Rep. 2011;4:1083–8.
Google Scholar
Wu Y, Li YY, Matsushima K, Baba T, Mukaida N. CCL3-CCR5 axis regulates intratumoral accumulation of leukocytes and fibroblasts and promotes angiogenesis in murine lung metastasis process. J Immunol. 2008;181:6384–93.
Google Scholar
Mak CSL, Zhu M, Fu J, Liang X, Wang X, Yuan F, et al. KDM4A promotes NEPC progression through regulation of MYC expression. Cancer Lett. 2026;638:218184.
Google Scholar
Zhang Y, Mao D, Roswit WT, Jin X, Patel AC, Patel DA, et al. PARP9-DTX3L ubiquitin ligase targets host histone H2BJ and viral 3C protease to enhance interferon signaling and control viral infection. Nat Immunol. 2015;16:1215–27.
Google Scholar
Leszinski G, Gezer U, Siegele B, Stoetzer O, Holdenrieder S. Relevance of histone marks H3K9me3 and H4K20me3 in cancer. Anticancer Res. 2012;32:2199–205.
Google Scholar
Alavattam KG, Esparza JM, Hu M, Shimada R, Kohrs AR, Abe H, et al. ATF7IP2/MCAF2 directs H3K9 methylation and meiotic gene regulation in the male germline. Genes Dev. 2024;38:115–30.
Google Scholar
Feng S, Gui Y, Yin S, Xiong X, Liu K, Li J, et al. Histone demethylase KDM2A recruits HCFC1 and E2F1 to orchestrate male germ cell meiotic entry and progression. EMBO J. 2024;43:4197–227.
Google Scholar
Alamdar A, Tian M, Huang Q, Du X, Zhang J, Liu L, et al. Enhanced histone H3K9 tri-methylation suppresses steroidogenesis in rat testis chronically exposed to arsenic. Ecotoxicol Environ Saf. 2019;170:513–20.
Google Scholar
Cai X, Yu X, Tang T, Xu Y, Wu T. JMJD2A promotes the development of castration-resistant prostate cancer by activating androgen receptor enhancer and inhibiting the cGAS-STING pathway. Mol Carcinog. 2024;63:1682–96.
Google Scholar
Yang H, Liu X, Nie J, Wu S, Ma L, Jiang Y, et al. USP7 promotes chemotherapy resistance and DNA damage response through stabilizing and deubiquitinating KDM4A in bladder cancer. Cell Death Dis. 2025;17:123.
Google Scholar
Zhang J, Xu H, He Y, Zheng X, Lin T, Yang L, et al. Inhibition of KDM4A restricts SQLE transcription and induces oxidative stress imbalance to suppress bladder cancer. Redox Biol. 2024;77:103407.
Google Scholar
Pichavaram P, Jablonowski CM, Fang J, Fleming AM, Gil HJ, Boghossian AS, et al. Oncogenic cells of renal embryonic lineage sensitive to the small-molecule inhibitor QC6352 display depletion of KDM4 levels and disruption of ribosome biogenesis. Mol Cancer Therapeutics. 2024;23:478–91.
Google Scholar
Singla N, Bagrodia A, Baraban E, Fankhauser CD, Ged YMA. Testicular germ cell tumors: a review. JAMA. 2025;333:793–803.
Google Scholar
Pijuan J, Barceló C, Moreno DF, Maiques O, Sisó P, Marti RM, et al. In vitro cell migration, invasion, and adhesion assays: from cell imaging to data analysis. Front Cell Dev Biol. 2019;7:107.
Google Scholar
Gomperts BN, Strieter RM. Chemokine-directed metastasis. Contrib Microbiol. 2006;13:170–90.
Google Scholar
Hung SK, Yu CC, Lin HY, Chiou WY, Lee MS, Lin RI, et al. Targeting PADI2 as a potential therapeutic strategy against metastasis in oral cancer via suppressing EMT-mediated migration and invasion and CCL3/5-induced angiogenesis. Clin Exp Metastasis. 2024;41:925–35.
Google Scholar
Kitamura T, Qian BZ, Soong D, Cassetta L, Noy R, Sugano G, et al. CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages. J Exp Med. 2015;212:1043–59.
Google Scholar
Altıntaş UB, Seo JH, Giambartolomei C, Ozturan D, Fortunato BJ, Nelson GM, et al. Decoding the epigenetics and chromatin loop dynamics of androgen receptor-mediated transcription. Nat Commun. 2024;15:9494.
Google Scholar
